173 related articles for article (PubMed ID: 29546356)
1. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.
Li X; Arias CA; Aitken SL; Galloway Peña J; Panesso D; Chang M; Diaz L; Rios R; Numan Y; Ghaoui S; DebRoy S; Bhatti MM; Simmons DE; Raad I; Hachem R; Folan SA; Sahasarabhojane P; Kalia A; Shelburne SA
Clin Infect Dis; 2018 Jul; 67(3):398-406. PubMed ID: 29546356
[TBL] [Abstract][Full Text] [Related]
2. Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureus lineages.
Côrtes MF; André C; Martins Simões P; Corvec S; Caillon J; Tristan A; Bes M; Vandenesch F; Figueiredo AMS; Dupieux C; Laurent F
J Antimicrob Chemother; 2022 Jun; 77(7):1838-1846. PubMed ID: 35425984
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
Tewhey R; Gu B; Kelesidis T; Charlton C; Bobenchik A; Hindler J; Schork NJ; Humphries RM
mBio; 2014 May; 5(3):e00894-14. PubMed ID: 24915435
[TBL] [Abstract][Full Text] [Related]
4. Linezolid resistance in clinical isolates of Staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids.
Bender J; Strommenger B; Steglich M; Zimmermann O; Fenner I; Lensing C; Dagwadordsch U; Kekulé AS; Werner G; Layer F
J Antimicrob Chemother; 2015; 70(6):1630-8. PubMed ID: 25740949
[TBL] [Abstract][Full Text] [Related]
5. Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
Weßels C; Strommenger B; Klare I; Bender J; Messler S; Mattner F; Krakau M; Werner G; Layer F
J Antimicrob Chemother; 2018 May; 73(5):1185-1193. PubMed ID: 29438544
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Linezolid Resistance Among Clinical
Ruiz-Ripa L; Feßler AT; Hanke D; Eichhorn I; Azcona-Gutiérrez JM; Alonso CA; Pérez-Moreno MO; Aspiroz C; Bellés A; Schwarz S; Torres C
Microb Drug Resist; 2021 Feb; 27(2):145-153. PubMed ID: 32456543
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio.
Mendes RE; Deshpande LM; Bonilla HF; Schwarz S; Huband MD; Jones RN; Quinn JP
Antimicrob Agents Chemother; 2013 Jul; 57(7):2923-8. PubMed ID: 23571552
[TBL] [Abstract][Full Text] [Related]
8. Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children's hospital in Cracow, Poland.
Kosecka-Strojek M; Sadowy E; Gawryszewska I; Klepacka J; Tomasik T; Michalik M; Hryniewicz W; Miedzobrodzki J
Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1717-1725. PubMed ID: 32350737
[TBL] [Abstract][Full Text] [Related]
9. Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China.
Yang XJ; Chen Y; Yang Q; Qu TT; Liu LL; Wang HP; Yu YS
J Med Microbiol; 2013 Jun; 62(Pt 6):845-850. PubMed ID: 23449871
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Mendes RE; Deshpande LM; Costello AJ; Farrell DJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4656-61. PubMed ID: 22687512
[TBL] [Abstract][Full Text] [Related]
12. Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland.
O'Connor C; Powell J; Finnegan C; O'Gorman A; Barrett S; Hopkins KL; Pichon B; Hill R; Power L; Woodford N; Coffey JC; Kearns A; O'Connell NH; Dunne CP
J Hosp Infect; 2015 Aug; 90(4):316-21. PubMed ID: 25648941
[TBL] [Abstract][Full Text] [Related]
13. Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.
Brenciani A; Morroni G; Pollini S; Tiberi E; Mingoia M; Varaldo PE; Rossolini GM; Giovanetti E
J Antimicrob Chemother; 2016 Feb; 71(2):307-13. PubMed ID: 26472766
[TBL] [Abstract][Full Text] [Related]
14. Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit.
Papan C; Schröder M; Hoffmann M; Knoll H; Last K; Albrecht F; Geisel J; Fink T; Gärtner BC; Mellmann A; Volk T; Berger FK; Becker SL
Antimicrob Resist Infect Control; 2021 Jun; 10(1):99. PubMed ID: 34193293
[TBL] [Abstract][Full Text] [Related]
15. The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L.
LaMarre J; Mendes RE; Szal T; Schwarz S; Jones RN; Mankin AS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1173-9. PubMed ID: 23254434
[TBL] [Abstract][Full Text] [Related]
16. Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus.
Baos E; Candel FJ; Merino P; Pena I; Picazo JJ
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):325-9. PubMed ID: 23726146
[TBL] [Abstract][Full Text] [Related]
17. Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
Lazaris A; Coleman DC; Kearns AM; Pichon B; Kinnevey PM; Earls MR; Boyle B; O'Connell B; Brennan GI; Shore AC
J Antimicrob Chemother; 2017 Dec; 72(12):3252-3257. PubMed ID: 28961986
[TBL] [Abstract][Full Text] [Related]
18. The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China.
Liu C; Chen C; Ye Y; Li X; Sun J; Xu L; Ming L
Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114956. PubMed ID: 31813640
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23.
Martínez-Meléndez A; Morfín-Otero R; Villarreal-Treviño L; Camacho-Ortíz A; González-González G; Llaca-Díaz J; Rodríguez-Noriega E; Garza-González E
Braz J Infect Dis; 2016; 20(5):419-28. PubMed ID: 27393769
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
